Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Retained Earnings (2018 - 2025)

Avai Bio's Retained Earnings history spans 7 years, with the latest figure at -$3.0 million for Q1 2024.

  • On a quarterly basis, Retained Earnings fell 251.02% to -$3.0 million in Q1 2024 year-over-year; TTM through Mar 2024 was -$3.0 million, a 251.02% decrease, with the full-year FY2024 number at -$3.0 million, down 251.02% from a year prior.
  • Retained Earnings hit -$3.0 million in Q1 2024 for Avai Bio, down from -$2.7 million in the prior quarter.
  • Over the last five years, Retained Earnings for AVAI hit a ceiling of $1.7 million in Q3 2023 and a floor of -$3.0 million in Q1 2024.
  • Historically, Retained Earnings has averaged -$211271.0 across 5 years, with a median of -$5611.5 in 2021.
  • The widest YoY moves for Retained Earnings: up 26305.59% in 2023, down 501827.81% in 2023.
  • Tracing AVAI's Retained Earnings over 5 years: stood at -$385058.0 in 2020, then surged by 97.04% to -$11392.0 in 2021, then surged by 6418.87% to $719846.0 in 2022, then tumbled by 471.32% to -$2.7 million in 2023, then fell by 11.35% to -$3.0 million in 2024.
  • Business Quant data shows Retained Earnings for AVAI at -$3.0 million in Q1 2024, -$2.7 million in Q4 2023, and $1.7 million in Q3 2023.